New study aims to uncover why some women have worse sexual side effects from radiation

NCT ID NCT05394428

Recruiting now Knowledge-focused Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing 300 women with female sexual organs who are receiving radiotherapy for certain cancers. Researchers want to understand why some patients have more sexual side effects than others. They will track sexual quality of life and look at radiation doses to find patterns. The goal is to create models that predict side effects and eventually improve treatment techniques.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could lead to better ways to predict and reduce sexual side effects from radiotherapy, improving quality of life for female cancer patients.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly help participants. Results may not lead to immediate changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal carcinoma cancer cervical cancer neoplasm rectal cancer uterine cancer vaginal cancer vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALIGNANT NEOPLASMS

Contacts and locations

Locations

Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
M.D. Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.